Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2023 Filed Aug 28, 2023 13:41 UTC |
Purushothaman BalajiChief Human Resources Officer
|
SaleCommon Stock | 986 | $153.35 | $151,203.10 |
DisclosureSEC source: 0001127602-23-023277 · form4.xml · nonDerivative · entry 1 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,101.4543 Read SEC document |
| August 24, 2023 Filed Aug 25, 2023 16:24 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
SaleCommon Stock | 884 | $154.49 | $136,570.04 |
DisclosureSEC source: 0001127602-23-023203 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,073.1923 F1 · price: Weighted average price of the shares sold. The price range was $154.4901 to $154.50. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 24, 2023 Filed Aug 25, 2023 16:26 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 5,310 | $154.00 | $817,743.19 |
DisclosureSEC source: 0001127602-23-023205 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,028.2241 F1 · price: Weighted average price of the shares sold. The price range was $154.00 to $154.0075. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 23, 2023 Filed Aug 24, 2023 13:41 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 781 | $152.82 | $119,352.42 |
DisclosureSEC source: 0001127602-23-023162 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 6,310.443 Read SEC document |
| August 18, 2023 Filed Aug 21, 2023 15:13 UTC |
Coombe Gary ACEO - Grooming
|
SaleCommon Stock | 8,609 | $151.58 | $1,304,952.22 |
DisclosureSEC source: 0001127602-23-022999 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,989.5349 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 20:57 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 806 | $152.85 | $123,193.96 |
DisclosureSEC source: 0001127602-23-022956 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,372.7906 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 20:59 UTC |
Jejurikar ShaileshChief Operating Officer
|
SaleCommon Stock | 7,871 | $152.85 | $1,203,051.65 |
DisclosureSEC source: 0001127602-23-022957 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,657.1522 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 21:01 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
SaleCommon Stock | 110 | $152.85 | $16,813.07 |
DisclosureSEC source: 0001127602-23-022959 · form4.xml · nonDerivative · entry 2 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 35,421.5707 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2023 Filed Aug 18, 2023 21:01 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
SaleCommon Stock | 19,822 | $152.85 | $3,029,715.39 |
DisclosureSEC source: 0001127602-23-022959 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,145.091 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 14:38 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
SaleCommon Stock | 384 | $152.85 | $58,692.90 |
DisclosureSEC source: 0001127602-23-022991 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,957.1923 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 14:40 UTC |
Pritchard Marc S.Chief Brand Officer
|
SaleCommon Stock | 7,185 | $152.85 | $1,098,199.23 |
DisclosureSEC source: 0001127602-23-022992 · form4.xml · nonDerivative · entry 1 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,277.0282 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 14:41 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 8,258 | $152.85 | $1,262,203.09 |
DisclosureSEC source: 0001127602-23-022993 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,121.3574 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 14:47 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
SaleCommon Stock | 5,736 | $152.85 | $876,725.23 |
DisclosureSEC source: 0001127602-23-022994 · form4.xml · nonDerivative · entry 1 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,036.7149 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 14:49 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 668 | $152.85 | $102,101.19 |
DisclosureSEC source: 0001127602-23-022995 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 7,091.443 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 14:49 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 9,063 | $152.85 | $1,385,244.20 |
DisclosureSEC source: 0001127602-23-022995 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,338.2241 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 14:50 UTC |
Purushothaman BalajiChief Human Resources Officer
|
SaleCommon Stock | 826 | $152.85 | $126,250.88 |
DisclosureSEC source: 0001127602-23-022996 · form4.xml · nonDerivative · entry 1 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,087.4543 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 14:51 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
SaleCommon Stock | 789 | $152.85 | $120,595.57 |
DisclosureSEC source: 0001127602-23-022997 · form4.xml · nonDerivative · entry 1 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,682.9887 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 14:58 UTC |
Davis Jennifer L.CEO - Health Care
|
SaleCommon Stock | 5,761 | $152.85 | $880,546.38 |
DisclosureSEC source: 0001127602-23-022998 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,148.7198 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 15:14 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
GrantCommon Stock | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022907 · form4.xml · nonDerivative · entry 2 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 35,531.5707 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 15:14 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
GrantCommon Stock | 42,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022907 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,967.091 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 15:16 UTC |
Davis Jennifer L.CEO - Health Care
|
GrantCommon Stock | 12,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022908 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,909.7198 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 15:23 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantCommon Stock | 19,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022911 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,528.1522 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 15:25 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantCommon Stock | 15,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022912 · form4.xml · nonDerivative · entry 1 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,462.0282 F1 · price: Stock Award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 15:29 UTC |
Schulten AndreChief Financial Officer
|
GrantCommon Stock | 1,768 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022913 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,178.7906 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 15:31 UTC |
Purushothaman BalajiChief Human Resources Officer
|
GrantCommon Stock | 1,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022914 · form4.xml · nonDerivative · entry 1 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,913.4543 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 15:32 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantCommon Stock | 1,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022915 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,341.1923 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 15:33 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantCommon Stock | 1,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022916 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 7,759.443 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 15:33 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantCommon Stock | 19,682 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022916 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,401.2241 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 15:35 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantCommon Stock | 2,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022917 · form4.xml · nonDerivative · entry 1 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,471.9887 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 15:36 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
GrantCommon Stock | 12,456 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022918 · form4.xml · nonDerivative · entry 1 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,772.7149 F1 · price: Stock Award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 15:37 UTC |
Coombe Gary ACEO - Grooming
|
GrantCommon Stock | 18,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022919 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,598.5349 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 15:39 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
GrantCommon Stock | 18,412 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022920 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,379.3574 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 15, 2023 Filed Aug 18, 2023 15:14 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
GrantRestricted Stock Units · Derivative | 158.436 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022907 · form4.xml · derivative · entry 4 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,129.0783 Underlying: Common Stock · 158.436 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 15, 2023 Filed Aug 18, 2023 15:16 UTC |
Davis Jennifer L.CEO - Health Care
|
GrantRestricted Stock Units · Derivative | 12.2891 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022908 · form4.xml · derivative · entry 3 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67.5879 Underlying: Common Stock · 12.2891 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 15, 2023 Filed Aug 18, 2023 15:23 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 22.289 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022911 · form4.xml · derivative · entry 6 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 327.443 Underlying: Common Stock · 22.289 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 15, 2023 Filed Aug 18, 2023 15:25 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantRestricted Stock Units · Derivative | 185.8527 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022912 · form4.xml · derivative · entry 7 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,099.2511 Underlying: Common Stock · 185.8527 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 15, 2023 Filed Aug 18, 2023 15:29 UTC |
Schulten AndreChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 8.1253 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022913 · form4.xml · derivative · entry 3 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46.021 Underlying: Common Stock · 8.1253 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 15, 2023 Filed Aug 18, 2023 15:32 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantRestricted Stock Units · Derivative | 0.5742 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022915 · form4.xml · derivative · entry 3 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2.4112 Underlying: Common Stock · 0.5742 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 15, 2023 Filed Aug 18, 2023 15:33 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantRestricted Stock Units · Derivative | 39.4422 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022916 · form4.xml · derivative · entry 5 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 642.6455 Underlying: Common Stock · 39.4422 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 15, 2023 Filed Aug 18, 2023 15:35 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantRestricted Stock Units · Derivative | 4.9834 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022917 · form4.xml · derivative · entry 4 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28.7287 Underlying: Common Stock · 4.9834 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 15, 2023 Filed Aug 18, 2023 15:36 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
GrantRestricted Stock Units · Derivative | 10.6076 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022918 · form4.xml · derivative · entry 3 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69.3118 Underlying: Common Stock · 10.6076 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 15, 2023 Filed Aug 18, 2023 15:37 UTC |
Coombe Gary ACEO - Grooming
|
GrantRestricted Stock Units · Derivative | 36.0507 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022919 · form4.xml · derivative · entry 4 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 688.3993 Underlying: Common Stock · 36.0507 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 15, 2023 Filed Aug 18, 2023 15:39 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
GrantRestricted Stock Units · Derivative | 31.5227 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022920 · form4.xml · derivative · entry 4 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 432.3108 Underlying: Common Stock · 31.5227 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 19:59 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-23-022278 · form4.xml · derivative · entry 5 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,289 Underlying: Common Stock · 30,000 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 19:59 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 30,000 | $158.01 | $4,740,363.00 |
DisclosureSEC source: 0001127602-23-022278 · form4.xml · nonDerivative · entry 2 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 961.7042 F1 · price: Weighted average price of the shares sold. The price range was $158.00 to $158.03. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 09, 2023 Filed Aug 10, 2023 19:59 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionCommon Stock | 30,000 | $91.07 | $2,732,100.00 |
DisclosureSEC source: 0001127602-23-022278 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,961.7042 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2023 Filed Aug 3, 2023 20:00 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
GrantRestricted Stock Units · Derivative | 2,144 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-021933 · form4.xml · derivative · entry 6 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,144 Underlying: Common Stock · 2,144 shares Expires not disclosed F7 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 03, 2023 Filed Aug 5, 2023 00:23 UTC |
Davis Jennifer L.CEO - Health Care
|
GrantRestricted Stock Units · Derivative | 791 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022047 · form4.xml · derivative · entry 5 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 791 Underlying: Common Stock · 791 shares Expires not disclosed F7 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 03, 2023 Filed Aug 5, 2023 00:25 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
GrantRestricted Stock Units · Derivative | 960 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022048 · form4.xml · derivative · entry 4 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 960 Underlying: Common Stock · 960 shares Expires not disclosed F1 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023. F2 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F2 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 03, 2023 Filed Aug 5, 2023 00:26 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
GrantCommon Stock | 86 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-022049 · form4.xml · nonDerivative · entry 1 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 973.9068 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.